850
Views
4
CrossRef citations to date
0
Altmetric
Reviews

The evolving role of lenalidomide in non-Hodgkin lymphoma

, &
Pages 1507-1516 | Received 07 Nov 2015, Accepted 22 Jan 2016, Published online: 22 Feb 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Bruna Maria Bereta Souza, Fernanda Bernadelli De Vito, Marianna Licati Calado, Marcos Vinícius Silva, Leonardo Rodrigues Oliveira, Virmondes Rodrigues-Júnior & Helio Moraes-Souza. (2018) Evaluation of the cytotoxic response mediated by perforin and granzyme B in patients with non-Hodgkin lymphoma. Leukemia & Lymphoma 59:1, pages 214-220.
Read now
Punit L. Jain, Carrie Anne Orlikowski & Alessandra Ferrajoli. (2016) Lenalidomide in chronic lymphocytic leukemia. Expert Opinion on Orphan Drugs 4:9, pages 971-980.
Read now

Articles from other publishers (2)

Dia Advani, Sudhanshu Sharma, Smita Kumari, Rashmi K. Ambasta & Pravir Kumar. (2022) Precision Oncology, Signaling, and Anticancer Agents in Cancer Therapeutics. Anti-Cancer Agents in Medicinal Chemistry 22:3, pages 433-468.
Crossref
Sarah A. Holstein, Jens Hillengass & Philip L. McCarthy. (2018) Next-Generation Drugs Targeting the Cereblon Ubiquitin Ligase. Journal of Clinical Oncology 36:20, pages 2101-2104.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.